Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Bros. Advisors (gp) Llc
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   608,718    

Indirect Shares

  158,658,441      
Direct Value   $43,029,120    

Indirect Value

  $12,788,968,670      
Total Shares   159,267,159      
Total Value   $12,831,997,790      


Incyte Corp
 $32,360,262 Synageva BioPharma Corp
 $0 Mirati Therapeutics, Inc.
 $16,084 Seagen Inc
 $10,649,448 Neurogene
 $3,327 Incyte Corp
 $32,360,262 Synageva BioPharma Corp
 $0 Mirati Therapeutics, Inc.
 $16,084 Seagen Inc
 $10,649,448 Neurogene
 $3,327
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -75.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genomic Health Inc GHDX Director, 10% Owner 2013-07-01 0 2019-02-27 9,235,362    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2014-03-05 0 2016-04-01 41,897,946    Premium*  
            Incyte Corp INCY Director, 10% Owner 2021-05-14 559,963 2021-05-14 29,367,926    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2014-05-22 0 2014-05-22 518,849    Premium*  
            Aceragen, Inc ACGN Director 2014-07-01 0 2016-01-04 78,885    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-01-07 1,020 2015-01-07 11,877,394    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2016-06-09 274 2016-06-09 30,003    Premium*  
            Intellia Therapeutics, Inc. NTLA Former 10% owner 2016-05-11 0 2016-05-11 976,214    Premium*  
            Invitae Corp NVTA 10% Owner 2016-11-17 0 2016-11-17 6,554,039    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2017-03-24 0 2023-11-22 2,168,818    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2023-05-31 46,557 2023-05-31 42,977,301    Premium*  
            Neurogene NGNE Director, 10% Owner 2023-10-05 904 2023-10-05 1,658,190    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 2022-05-16 0 2022-06-06 4,501,658    Premium*  
            Atreca Inc BCEL Former 10% Owner 2023-10-19 0 2023-10-19 2,971,128    Premium*  
            Igm Biosciences, Inc. IGMS 2023-12-13 0 2024-03-29 3,755,474    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-03-05 0 2024-03-05 89,254    Premium*  
* Premium Members only  

Records found :    103         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
INCY Incyte Corp Director   –       •       •   2015-09-16 4 OE $0.00 $0 I/I 4,609,228 512,673 0 -
ACGN Aceragen, Inc Director   –       •      –    2015-10-01 4 A $3.06 $63,755 I/I 20,835 71,803 0 -
INCY Incyte Corp Director   –       •       •   2015-10-01 4 A $110.33 $56,930 I/I 516 512,845 0 -
INCY Incyte Corp Director   –       •       •   2015-12-31 4 A $108.45 $56,936 I/I 525 513,020 0 -
ACGN Aceragen, Inc Director   –       •      –    2016-01-04 4 A $3.00 $63,738 I/I 21,246 78,885 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2016-01-07 4/A B $29.00 $74,999,974 I/I 2,586,206 20,278,008 2.25 -
INCY Incyte Corp Director   –       •       •   2016-02-11 4 B $58.13 $82,297,659 I/I 1,328,897 17,326,770 2.25 -
INCY Incyte Corp Director   –       •       •   2016-02-12 4 B $63.98 $14,010,424 I/I 208,677 18,346,124 2.25 -
INCY Incyte Corp Director   –       •       •   2016-02-12 4 B $64.87 $60,732,037 I/I 922,530 18,158,080 2.25 -
INCY Incyte Corp Director   –       •       •   2016-02-16 4 B $69.45 $47,973,373 I/I 678,488 18,958,070 2.25 -
INCY Incyte Corp Director   –       •       •   2016-02-24 4 B $69.70 $4,055,187 I/I 57,590 19,009,830 2.25 -
INCY Incyte Corp Director   –       •       •   2016-02-25 4 B $74.00 $495,800 I/I 6,700 19,015,852 2.25 -
INCY Incyte Corp Director   –       •       •   2016-03-15 4 B $65.29 $26,588,417 I/I 400,000 19,376,568 2.25 -
INCY Incyte Corp Director   –       •       •   2016-03-17 4 B $60.85 $24,595,777 I/I 400,000 19,757,285 2.25 -
INCY Incyte Corp Director   –       •       •   2016-03-17 4 OE $3.86 $231,600 I/I 60,000 533,020 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2016-03-30 4 B $25.92 $12,000,056 I/I 462,546 2,799,646 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2016-03-31 4 B $25.61 $18,601,180 I/I 683,644 20,894,327 2.25 -
INCY Incyte Corp Director   –       •       •   2016-03-31 4 A $72.47 $56,961 I/I 786 533,282 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2016-04-01 4 B $27.82 $8,638,572 I/I 302,900 21,167,398 2.25 -
INCY Incyte Corp Director   –       •       •   2016-06-30 4 A $79.98 $56,866 I/I 711 533,519 0 -
INCY Incyte Corp Director   –       •       •   2016-09-30 4 A $94.29 $56,857 I/I 603 533,720 0 -
INCY Incyte Corp Director   –       •       •   2017-02-17 4 A $0.00 $0 I/I 10,610,782 767,095 0 -
GHDX Genomic Health Inc Director   –       •       •   2018-04-01 4 A $31.29 $119,778 I/I 3,828 339,585 0 -
GHDX Genomic Health Inc Director   –       •       •   2018-11-16 4 S $76.35 $6,699,000 I/I (87,395) 10,672,645 0 -
GHDX Genomic Health Inc Director   –       •       •   2018-11-26 4 S $74.05 $2,947,113 I/I (39,675) 10,639,954 0 -

  103  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed